Citation: | LIN Ni, KE Qu-qing, JIANG Ling-yan, OU Lan-zhi, LIU Die-mei, WU Yu-yan, DU Qing-feng. The clinical application value of homocysteine[J]. Chinese Journal of General Practice, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060 |
[1] |
徐炳欣, 赵艳, 段淑娟, 等. 亚甲基四氢叶酸还原酶a1298c基因多态性检测在高同型半胱氨酸血症治疗中的价值[J]. 中华全科医学, 2020, 18(9): 1470-1473. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202009012.htm
|
[2] |
MOON H, KO H, KIM A. Hyperhomocysteinemia concurrent with metabolic syndrome is independently associated with chronic kidney disease among Community-Dwelling adults in an urban korean population. [J]. Int J Env Res Pub He, 2020, 17(18): 6810. doi: 10.3390/ijerph17186810
|
[3] |
XU R, HUANG F, WANG Y, et al. Gender- and age-related differences in homocysteine concentration: A cross-sectional study of the general population of China[J]. Sci Rep-Uk, 2020, 10(1): 17401. doi: 10.1038/s41598-020-74596-7
|
[4] |
LU S S, XIE J, SU C Q, et al. Plasma homocysteine levels and intracranial plaque characteristics: Association and clinical relevance in ischemic stroke[J]. Bio Med Central, 2018, 18(1): 200. doi: 10.1186%2Fs12883-018-1203-4.pdf
|
[5] |
ZOU J, CHEN Z, LIANG C, et al. Trefoil factor 3, cholinesterase and homocysteine: Potential predictors for Parkinson's disease dementia and vascular parkinsonism dementia in advanced stage[J]. Aging Dis, 2018, 9(1): 51-65. doi: 10.14336/AD.2017.0416
|
[6] |
SANTOTORIBIO J D, DEL V L, GARCÍA-DE L T A, et al. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion[J]. PLoS One, 2019, 14(9): e0222616. http://www.researchgate.net/publication/336025378_The_diagnostic_value_of_pleural_fluid_homocysteine_in_malignant_pleural_effusion
|
[7] |
CHANG Y, LI Y, GUO X, et al. The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: A Cross-Sectional study from northeast China[J]. Int J Env Res Pub He, 2017, 14(4): 376. doi: 10.3390/ijerph14040376
|
[8] |
SUN P, WANG Q, ZHANG Y, et al. Association between homocysteine level and blood pressure traits among Tibetans: A cross-sectional study in China[J]. Medicine, 2019, 98(27): e16085. doi: 10.1097/MD.0000000000016085
|
[9] |
王红, 康小琴, 谢文博, 等. 血浆同型半胱氨酸和高敏c反应蛋白水平与h型高血压患者左心室肥厚的关系[J]. 中国医药, 2019, 14(11): 1606-1609. doi: 10.3760/j.issn.1673-4777.2019.11.002
|
[10] |
ZHOU F, HOU D, WANG Y, et al. Evaluation of H-type hypertension prevalence and its influence on the risk of increased carotid intima-media thickness among a high-risk stroke population in Hainan Province, China[J]. Medicine (Baltimore), 2020, 99(35): e21953. doi: 10.1097/MD.0000000000021953
|
[11] |
何菁, 蒋利, 顾北音, 等. 高血压患者血浆同型半胱氨酸与血压变异的相关性[J]. 中国临床医学, 2017, 24(6): 920-923. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX201706017.htm
|
[12] |
WANG W W, WANG X S, ZHANG Z R, et al. A meta-analysis of folic acid in combination with anti-Hypertension drugs in patients with hypertension and hyperhomocysteinemia[J]. Front Pharmacol, 2017, 31(8): 585. doi: 10.3389/fphar.2017.00585/pdf
|
[13] |
WANG Y, JIN Y, WANG Y, et al. The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2019, 98(37): e17095. doi: 10.1097/MD.0000000000017095
|
[14] |
CHRYSANT S G, CHRYSANT G S. The current status of homocysteine as a risk factor for cardiovascular disease: A mini review[J]. Expert review of cardiovascular therapy, 2018, 16(8): 559-565. doi: 10.1080/14779072.2018.1497974
|
[15] |
HASAN T, ARORA R, BANSAL A K, et al. Disturbed homocysteine metabolism is associated with cancer[J]. Exp Mol Med, 2019, 51(2): 1-13. http://www.onacademic.com/detail/journal_1000041601204699_5db2.html
|
[16] |
XU J, ZHAO X, SUN S, et al. Homocysteine and digestive tract cancer risk: A dose-response meta-analysis[J]. J Oncol, 2018, 2018(18): 3720684. http://www.onacademic.com/detail/journal_1000041641508099_855f.html
|
[17] |
HOUGHTON S C, ELIASSEN A H, ZHANG S M, et al. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women[J]. Breast Cancer Res Treat, 2019, 176(1): 191-203. doi: 10.1007/s10549-019-05223-x
|
[18] |
李亚芹, 闫勇, 张倡誌, 等. 胃癌患者化疗前后血清β2微球蛋白、视黄醇结合蛋白、Hcy水平及T淋巴细胞亚群的变化及临床意义[J]. 癌症进展, 2019, 17(5): 585-588. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201905024.htm
|
[19] |
PLATT D E, HARIRI E, SALAMEH P, et al. Type Ⅱ diabetes mellitus and hyperhomocysteinemia: A complex interaction[J]. Diabetol Metab Syndr, 2017, 2017(9): 19. http://www.onacademic.com/detail/journal_1000039897110410_b992.html
|
[20] |
MUZUROV I C ' E, KRALJEV I C ' I, SOLAK M, et al. Homocysteine and diabetes: Role in macrovascular and microvascular complications[J]. J Diabetes Complications, 2021, 35(3): 107834. doi: 10.1016/j.jdiacomp.2020.107834
|
[21] |
RUJASWINI T, DEVANANDAN P, RANADHEER C P, et al. A review on association of serum homocysteine in diabetic neuropathy[J]. Drug Invention Today, 2018, 10(2): 154-156. http://www.researchgate.net/profile/Praveen_Devanandan/publication/324965481_A_review_on_association_of_serum_homocysteine_in_diabetic_neuropathy/links/5aee9f970f7e9b01d3e18cbb/A-review-on-association-of-serum-homocysteine-in-diabetic-neuropathy.pdf
|
[22] |
曾金海. 同型半胱氨酸及血尿酸与2型糖尿病血管并发症的关系[J]. 中国临床新医学, 2017, 10(8): 786-788. doi: 10.3969/j.issn.1674-3806.2017.08.22
|
[23] |
WANG X, ZHOU Y, ZHANG M, et al. The methylenetetrahydrofolate reductase genotype 677CT and non-alcoholic fatty liver disease have a synergistic effect on the increasing homocysteine levels in subjects from Chongqing, China[J]. Genes Dis, 2019, 6(1): 88-95. doi: 10.1016/j.gendis.2018.07.003
|
[24] |
王传池, 胡镜清, 彭锦, 等. H型高血压脑卒中高发的病机探析[J]. 中国中医基础医学杂志, 2017, 23(2): 161-163. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201702007.htm
|
[25] |
GAIDAY A N, TUSSUPKALIYEV A B, BERMAGAMBETOVA S K, et al. Effect of homocysteine on pregnancy: A systematic review[J]. Chem Biol Interact, 2018, 2018(293): 70-76. http://www.researchgate.net/profile/Andrey_Gaiday2/publication/326574384_Effect_of_homocysteine_on_pregnancy_A_systematic_review/links/5b9bd8bd45851574f7cb315b/Effect-of-homocysteine-on-pregnancy-A-systematic-review.pdf
|
[26] |
AZZINI E, RUGGERI S, POLITO A. Homocysteine: Its possible emerging role in At-Risk population groups[J]. Int J Mol Sci, 2020, 21(4): 1421. doi: 10.3390/ijms21041421
|
[27] |
MAGED A M, SAAD H, MESHAAL H, et al. Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation[J]. Arch Gynecol Obstet, 2017, 296(3): 475-482. doi: 10.1007/s00404-017-4457-y
|
[28] |
SUN F, QIAN W, ZHANG C, et al. Correlation of maternal serum homocysteine in the first trimester with the development of gestational hypertension and preeclampsia[J]. Med Sci Monit, 2017, 23(11): 5396-5401. http://www.onacademic.com/detail/journal_1000040879149110_3f79.html
|
[29] |
乐元芬. 胎儿生长受限孕妇妊娠晚期血清同型半胱氨酸表达水平及意义[J]. 中国妇幼保健, 2017, 32(6): 1184-1185. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201706023.htm
|
[30] |
KONG X, MA X, ZHANG C, et al. Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort[J]. Int Urol Nephrol, 2017, 49(4): 661-667. doi: 10.1007/s11255-016-1452-3
|
[31] |
ZHOU Y F, GUAN Y F. Hyperhomocysteinemia and kidney diseases[J]. Sheng Li Xue Bao, 2018, 70(6): 607-611. http://www.ncbi.nlm.nih.gov/pubmed/30560269
|
[32] |
KUANG Z M, WANG Y, FENG S J, et al. Association between plasma homocysteine and microalbuminuria in untreated patients with essential hypertension: A case-control study[J]. Kidney Blood Press Res, 2017, 42(6): 1303-1311. doi: 10.1159/000486013
|
[33] |
范斌, 李晓玉, 张萍. 老年男性血浆同型半胱氨酸水平与髋关节骨密度的相关性分析[J]. 中国医药导报, 2021, 18(3): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202103025.htm
|
[34] |
BEHERA J, BALA J, NURU M, et al. Homocysteine as a pathological biomarker for bone disease[J]. J Cell Physiol, 2017, 232(10): 2704-2709. doi: 10.1002/jcp.25693
|
[35] |
OHISHI T, FUJITA T, NISHIDA T, et al. Factors influencing serum homocysteine levels in postmenopausal osteoporotic females - comparison to urinary collagen crosslinks[J]. Endocr Res, 2019, 44(3): 117-125. doi: 10.1080/07435800.2019.1577892
|
[36] |
董丽娟, 高飞. 骨密度及骨代谢指标与同型半胱氨酸关系的研究进展[J]. 中国骨质疏松杂志, 2020, 26(8): 1241-1244. doi: 10.3969/j.issn.1006-7108.2020.08.031
|
[37] |
LEI X, ZENG G, ZHANG Y, et al. Association between homocysteine level and the risk of diabetic retinopathy: A systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2018, 2018(10): 61. http://www.onacademic.com/detail/journal_1000040484067510_990c.html
|
[38] |
PINNA A, ZACCHEDDU F, BOSCIA F, et al. Homocysteine and risk of age-related macular degeneration: A systematic review and meta-analysis[J]. Acta Ophthalmol, 2018, 96(3): e269-e276. doi: 10.1111/aos.13343
|
[39] |
JENKINS D, SPENCE J D, GIOVANNUCCI E L, et al. Supplemental vitamins and minerals for CVD prevention and treatment[J]. J Am Coll Cardiol, 2018, 71(22): 2570-2584. doi: 10.1016/j.jacc.2018.04.020
|
[40] |
SPENCE J D. Nutrition and risk of stroke[J]. Nutrients, 2019, 11(3): 647. doi: 10.3390/nu11030647
|
[41] |
SPENCE J D, YI Q, HANKEY G J. B vitamins in stroke prevention: Time to reconsider[J]. Lancet Neurol, 2017, 16(9): 750-760. doi: 10.1016/S1474-4422(17)30180-1
|
[42] |
SPENCE J D, HACHINSKI V. B vitamins for stroke prevention: Interaction of low platelet count and high plasma total homocysteine[J]. J Am Coll Cardiol, 2018, 71(19): 2147-2148. doi: 10.1016/j.jacc.2018.03.024
|
[43] |
LIND M V, LAURITZEN L, KRISTENSEN M, et al. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: A meta-analysis of randomized controlled trials[J]. Am J Clin Nutr, 2019, 109(1): 29-42. doi: 10.1093/ajcn/nqy234
|
[44] |
KAGAWA Y, HIRAOKA M, KAGEYAMA M, et al. Medical cost savings in Sakado City and worldwide achieved by preventing disease by folic acid fortification[J]. Congenit Anom (Kyoto), 2017, 57(5): 157-165. doi: 10.1111/cga.12215
|